To investigate the role of BAP31 in GC progression, GC cells were chosen for loss- or gain-of-function studies based on their low or high endogenous BAP31 expression, respectively (Supplementary Fig. S2A, Fig. 2A). The gene discussed is BCAP31; the disease is gastric cancer.